A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines
Top Cited Papers
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 46 (6) , 840-849
- https://doi.org/10.1067/mjd.2002.121356
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open‐label studyOtolaryngology -- Head and Neck Surgery, 2000
- Botulinum Toxin Type A as a Migraine Preventive TreatmentHeadache: The Journal of Head and Face Pain, 2000
- Patient Selection in the Treatment of Glabellar Wrinkles With Botulinum Toxin Type A InjectionJAMA Otolaryngology–Head & Neck Surgery, 1997
- Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection techniqueJournal of the American Academy of Dermatology, 1996
- Botulinum Toxin A for Hyperkinetic Facial Lines: Results of a Double-Blind, Placebo-Controlled StudyPlastic and Reconstructive Surgery, 1994
- Aesthetic Indications for Botulinum Toxin InjectionPlastic and Reconstructive Surgery, 1994
- Botulinum Toxin for the Treatment of Hyperfunctional Lines of the FaceJAMA Otolaryngology–Head & Neck Surgery, 1993
- Botulinum A Toxin for (Expressionistic) Ptosis Overcorrection After Frontalis SlingOphthalmic Plastic & Reconstructive Surgery, 1992
- Treatment of Glabellar Frown Lines with C. Botulinum‐A ExotoxinThe Journal of Dermatologic Surgery and Oncology, 1992
- BLINDNESS FOLLOWING FAT INJECTIONSPlastic and Reconstructive Surgery, 1988